Your browser doesn't support javascript.
loading
eIF6 is potential diagnostic and prognostic biomarker that associated with 18F-FDG PET/CT features and immune signatures in esophageal carcinoma.
Gao, Yan; Yuan, Lingling; Zeng, Jing; Li, Fuyan; Li, Xiaohui; Tan, Fan; Liu, Xusheng; Wan, Huabing; Kui, Xueyan; Liu, Xiaoyu; Ke, Changbin; Pei, Zhijun.
Afiliación
  • Gao Y; Department of Nuclear Medicine and Institute of Anesthesiology and Pain, and Department of Pathology, Taihe Hospital, Hubei University of Medicine, No. 32, Renmin Road, Shiyan, 442000, China.
  • Yuan L; Department of Nuclear Medicine and Institute of Anesthesiology and Pain, and Department of Pathology, Taihe Hospital, Hubei University of Medicine, No. 32, Renmin Road, Shiyan, 442000, China.
  • Zeng J; Department of Nuclear Medicine and Institute of Anesthesiology and Pain, and Department of Pathology, Taihe Hospital, Hubei University of Medicine, No. 32, Renmin Road, Shiyan, 442000, China.
  • Li F; Department of Nuclear Medicine and Institute of Anesthesiology and Pain, and Department of Pathology, Taihe Hospital, Hubei University of Medicine, No. 32, Renmin Road, Shiyan, 442000, China.
  • Li X; Department of Nuclear Medicine and Institute of Anesthesiology and Pain, and Department of Pathology, Taihe Hospital, Hubei University of Medicine, No. 32, Renmin Road, Shiyan, 442000, China.
  • Tan F; Department of Nuclear Medicine and Institute of Anesthesiology and Pain, and Department of Pathology, Taihe Hospital, Hubei University of Medicine, No. 32, Renmin Road, Shiyan, 442000, China.
  • Liu X; Department of Nuclear Medicine and Institute of Anesthesiology and Pain, and Department of Pathology, Taihe Hospital, Hubei University of Medicine, No. 32, Renmin Road, Shiyan, 442000, China.
  • Wan H; Department of Nuclear Medicine and Institute of Anesthesiology and Pain, and Department of Pathology, Taihe Hospital, Hubei University of Medicine, No. 32, Renmin Road, Shiyan, 442000, China.
  • Kui X; Department of Nuclear Medicine and Institute of Anesthesiology and Pain, and Department of Pathology, Taihe Hospital, Hubei University of Medicine, No. 32, Renmin Road, Shiyan, 442000, China.
  • Liu X; Department of Nuclear Medicine and Institute of Anesthesiology and Pain, and Department of Pathology, Taihe Hospital, Hubei University of Medicine, No. 32, Renmin Road, Shiyan, 442000, China.
  • Ke C; Department of Nuclear Medicine and Institute of Anesthesiology and Pain, and Department of Pathology, Taihe Hospital, Hubei University of Medicine, No. 32, Renmin Road, Shiyan, 442000, China. changbinke-iap@taihehospital.com.
  • Pei Z; Department of Nuclear Medicine and Institute of Anesthesiology and Pain, and Department of Pathology, Taihe Hospital, Hubei University of Medicine, No. 32, Renmin Road, Shiyan, 442000, China. pzjzml1980@taihehospital.com.
J Transl Med ; 20(1): 303, 2022 07 06.
Article en En | MEDLINE | ID: mdl-35794622
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma de Células Escamosas / Fluorodesoxiglucosa F18 Tipo de estudio: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: J Transl Med Año: 2022 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma de Células Escamosas / Fluorodesoxiglucosa F18 Tipo de estudio: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: J Transl Med Año: 2022 Tipo del documento: Article País de afiliación: China